$3.72
N/A
Last update: Nov 5, 4:00 PM
Camp4 Therapeutics Corp
CAMPNASDAQ
The average analyst price target for Camp4 Therapeutics is $10.33, 177.7% above the current price. Of 12 analysts, 11 rate it Buy and 1 Sell. Targets range from $6 to $23. The latest change came on Oct 23, 2026, when Raymond James initiated coverage of Camp4 Therapeutics with a Strong Buy rating and a $10 price target.
Price Target Range — 8 Quarters
Analyst Consensus — 12 Analysts
Rating Trend — Last 9 Months
